11-77156921-G-A

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5

The NM_000260.4(MYO7A):​c.652G>A​(p.Asp218Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000514 in 1,613,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D218H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

MYO7A
NM_000260.4 missense

Scores

9
6
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:7U:1

Conservation

PhyloP100: 9.92
Variant links:
Genes affected
MYO7A (HGNC:7606): (myosin VIIA) This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 8 uncertain in NM_000260.4
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.917
PP5
Variant 11-77156921-G-A is Pathogenic according to our data. Variant chr11-77156921-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 29924.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=1, Uncertain_significance=1, Likely_pathogenic=2}. Variant chr11-77156921-G-A is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYO7ANM_000260.4 linkuse as main transcriptc.652G>A p.Asp218Asn missense_variant 7/49 ENST00000409709.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYO7AENST00000409709.9 linkuse as main transcriptc.652G>A p.Asp218Asn missense_variant 7/491 NM_000260.4 Q13402-1
MYO7AENST00000458637.6 linkuse as main transcriptc.652G>A p.Asp218Asn missense_variant 7/491 P1Q13402-2
MYO7AENST00000409619.6 linkuse as main transcriptc.619G>A p.Asp207Asn missense_variant 8/501 Q13402-8

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152200
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000441
AC:
11
AN:
249160
Hom.:
0
AF XY:
0.0000222
AC XY:
3
AN XY:
135190
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000513
AC:
75
AN:
1461672
Hom.:
0
Cov.:
32
AF XY:
0.0000454
AC XY:
33
AN XY:
727122
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000567
Gnomad4 OTH exome
AF:
0.0000828
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152200
Hom.:
0
Cov.:
33
AF XY:
0.0000673
AC XY:
5
AN XY:
74338
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000759
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:7Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 09, 2024This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 218 of the MYO7A protein (p.Asp218Asn). This variant is present in population databases (rs201539845, gnomAD 0.02%). This missense change has been observed in individual(s) with autosomal dominant non-syndromic deafness (PMID: 21150918, 27911912). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 29924). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYO7A protein function with a negative predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Likely pathogenic, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely pathogenic, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxJan 31, 2022Reported as a heterozygous variant in unrelated individuals with non-syndromic hearing loss (Iwasa et al., 2016; Sakuma et al., 2016; Wu H et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27911912, 27018795, 25788563, 26763877, 21150918, 31589614) -
Autosomal dominant nonsyndromic hearing loss 11 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2011- -
Usher syndrome type 1B Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 17, 2017The p.Asp218Asn variant in MYO7A has been reported in 3 probands with a dominant family history of hearing loss, and segregated with disease in >10 affected rel atives from 2 families (Sun 2011, Iwasa 2016, LMM data). This variant has also b een identified in 8/34418 Latino chromosomes and in 5/126678 European chromosome s by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs201539845); however, pathogenic variants may be present at a low frequen cy in the general population. Although loss of function variants in MYO7A primar ily cause autosomal recessive Usher syndrome, several missense variants have bee n reported to segregate with autosomal dominant hearing loss (Street 2004, Luije ndijk 2004, Bolz 2004, Liu 1997, Sun 2011, Sang 2013). While the underlying mech anism is unknown, these missense variants are primarily located within the conse rved motor domain, which is the same domain impacted by the p.Asp218Asn variant. In summary, although additional studies are required to fully establish its cli nical significance, the p.Asp218Asn variant is likely pathogenic for autosomal d ominant nonsyndromic hearing loss. ACMG/AMP criteria applied: PM1_Strong, PM2_Su pporting, PM3 -
See cases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert EinsteinOct 09, 2019ACMG classification criteria: PP1, PP3 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.83
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.84
D;T;.;.
Eigen
Pathogenic
0.95
Eigen_PC
Pathogenic
0.90
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
D;D;D;D
M_CAP
Uncertain
0.18
D
MetaRNN
Pathogenic
0.92
D;D;D;D
MetaSVM
Uncertain
0.37
D
MutationAssessor
Uncertain
2.3
M;.;M;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.90
D
PROVEAN
Uncertain
-4.0
D;.;D;D
REVEL
Pathogenic
0.65
Sift
Benign
0.041
D;.;D;D
Sift4G
Uncertain
0.058
T;T;T;T
Polyphen
1.0
D;.;.;.
Vest4
0.97
MVP
0.91
MPC
0.27
ClinPred
0.88
D
GERP RS
5.2
Varity_R
0.64
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201539845; hg19: chr11-76867967; COSMIC: COSV68684168; API